FASEB Science Research Conference: Protein Kinases and Protein Phosphorylation
FASEB Science Research Conference: Protein Kinases and Protein Phosphorylation
批准号:
10464756
负责人:
Alex Toker
金额:
$0.35万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2023-05-31
关键词:
AreaBiochemicalBiochemistryBiological ProcessBiologyCanadaCareer MobilityCellular biologyChemicalsClinicalCollaborationsCommunicationDataDevelopmentDiabetes MellitusDiagnosisDisciplineDiseaseDisease modelDrug IndustryDrug TargetingEducational workshopEventFDA approvedFacultyFertilizationFosteringFundingFutureGoalsGrowth and Development functionHealthHumanInflammationInflammatoryIslandKnowledgeLightingLinkMalignant NeoplasmsMediatingMedicineMentorsMetabolic DiseasesMetabolic syndromeMethodologyMethodsMiningMolecularNormal CellNova ScotiaOncologyPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPlayPreventionPrincipal InvestigatorProcessProtein EngineeringProtein KinaseProtein Kinase Protein PhosphorylationProtein phosphataseProteomeReportingResearchResearch PersonnelRoleScienceScientistSenior ScientistSignal TransductionSiteStructureStructure-Activity RelationshipStudentsSystemSystems BiologyTechnologyTimeTranslational ResearchUnderrepresented MinorityUnderrepresented PopulationsWomancareercareer developmentforgingfrontierhuman diseaseimprovedin vivo Modelinnovationinsightinterestkinase inhibitormeetingsminority scientistmultidisciplinarynext generationnovelnovel anticancer drugnovel therapeuticspostersprogramsrecruitsocialstructural biologysummer researchsymposiumtherapeutic developmenttherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Program Director/Principal Investigator (Last, First, Middle): Toker, A./Bennett, A.
Protein phosphorylation is vitally important in the molecular communications that control cellular state and
activity. It is a dynamic process mediated by kinases and phosphatases that are precisely regulated in normal
cells, and deregulated in many human diseases, including diabetes, inflammatory disease and cancer. The study
of the protein phosphorylation machinery and its function in signaling systems is a robustly active area of
research that has driven methodological and conceptual advances and is increasingly contributing to the
development of therapeutic options. Protein kinases are frequently deregulated in cancer, and they have been
the focus of intense recent interest by the pharmaceutical industry. Indeed, most new cancer drugs approved by
the FDA in the last several years target kinases, and there are hundreds of new kinase inhibitors under
development. This strong clinical connection provides an exciting link with translational science.
In this application, we request funds to support attendance of trainees, junior faculty and traditionally
underrepresented groups at the 2022 FASEB Summer Research conference on Protein Kinases and Protein
Phosphorylation. This biennial conference started in 1983, and is an important interdisciplinary gathering that
brings together scientists with diverse expertise to advance understanding of the biochemical mechanisms and
fundamental principles of phosphorylation events – a focus that distinguishes this meeting from others that deal
with signaling networks and systems approaches. This FASEB meeting has been, and continues to be, a primary
venue for the announcement of breakthroughs in the field, and has a long-standing goal to enhance, and
disseminate, knowledge that will lead to improved therapies to target aberrant kinase activity, and protein
phosphorylation, in human disease. The 2022 FASEB Science Research Conference on Protein Kinases and
Protein Phosphorylation aims to highlight recent, cutting-edge findings in the field of protein phosphorylation, to
bring together structural biology, biochemistry, systems biology, chemical biology, protein engineering, and
medicine. This will promote cross-fertilization among these normally separate disciplines to stimulate new lines
of research, as well as to enhance communication, collaboration, career advancement for the diverse scientists
in the field. The ultimate goal is to advance the field to obtain better understandings of the molecular mechanisms
that regulate important biological processes and facilitate the identification of critical targets for the diagnosis,
prevention, treatment, and cure of human diseases.
OMB No. 0925-0001/0002 (Rev. 01/18 Approved Through 03/31/2020) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
-
批准号:10246864
-
项目类别:
-
资助金额:$103.5万
-
财政年份:2020
-
负责人:Alex Toker
-
依托单位:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
-
批准号:10677761
-
项目类别:
-
资助金额:$97.51万
-
财政年份:2020
-
负责人:Alex Toker
-
依托单位:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
-
批准号:10471296
-
项目类别:
-
资助金额:$100.84万
-
财政年份:2020
-
负责人:Alex Toker
-
依托单位:
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
-
批准号:9903255
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2016
-
负责人:Alex Toker
-
依托单位:
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
-
批准号:9270532
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2016
-
负责人:Alex Toker
-
依托单位:
Identifying lincRNAs that Mediate PI 3 Kinase Dependent Breast Cancer
-
批准号:8610428
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2014
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:9812868
-
项目类别:
-
资助金额:$41.56万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:8870311
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:8559337
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
Novel regulation of PI3K/Akt to direct targeted breast cancer therapies
-
批准号:8702122
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2013
-
负责人:Alex Toker
-
依托单位:
FASEB Summer Research Conference on Lipid Signaling Pathways in Cancer
-
批准号:7329084
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:8024499
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7256658
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7579113
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7388910
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
The Akt and NFAT Pathway and the Regulaton of Cancer Cell Motility
-
批准号:7772392
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2007
-
负责人:Alex Toker
-
依托单位:
Role of PLCgamma and NFAT Signaling Pathway in Carcinoma
-
批准号:6604523
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
Role of PLCgamma and NFAT Signaling Pathway in Carcinoma
-
批准号:6910034
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
Role of NFAT and NFAT-Induced Genes in Carcinoma
-
批准号:8055453
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
Role of PLCgamma and NFAT Signaling Pathway in Carcinoma
-
批准号:6505993
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Alex Toker
-
依托单位:
海外基金